Vassilios Myrianthopoulos

6PUBLICATIONS
18CO-AUTHORS
Biologically active moleculesMetal cluster chemistryCancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 19, 2025
Discovery and Characterization of Uracil Derivatives Targeting the Set-and-Ring Domain of UHRF1.

Ifigeneia Akrani, Danai Driva, Efstratios Tsakalidis

|Oct 26, 2024
Discovery of Novel Inhibitors against ALS-Related SOD1(A4V) Aggregation through the Screening of a Chemical Library Using Differential Scanning Fluorimetry (DSF).

Maria Giannakou, Ifigeneia Akrani, Angeliki Tsoka

|Aug 29, 2024
Novel Pyrazino[1,2-a]indole-1,3(2H,4H)-dione Derivatives Targeting the Replication of Flaviviridae Viruses: Structural and Mechanistic Insights.

Erofili Giannakopoulou, Ifigeneia Akrani, George Mpekoulis

|Apr 30, 2021
Cockayne Syndrome Group B (CSB): The Regulatory Framework Governing the Multifunctional Protein and Its Plausible Role in Cancer.

Zoi Spyropoulou, Angelos Papaspyropoulos, Nefeli Lagopati

|Aug 23, 2020
Screening of Heteroaromatic Scaffolds against Cystathionine Beta-Synthase Enables Identification of Substituted Pyrazolo[3,4-c]Pyridines as Potent and Selective Orthosteric Inhibitors.

Anna-Maria Fantel, Vassilios Myrianthopoulos, Anastasios Georgoulis

|Oct 07, 2017
Combined Virtual and Experimental Screening for CK1 Inhibitors Identifies a Modulator of p53 and Reveals Important Aspects of in Silico Screening Performance.

Vassilios Myrianthopoulos, Olivier Lozach, Danae Zareifi

Pageof 1

Frequent Collaborators

3 joint publications

Emmanuel Mikros

2 joint publications

Grigoris Zoidis

1 joint publications

Laurent Meijer

1 joint publications

George Lamprinidis